IS8128A - Samsetningar sem fela í sér paroxetín og 2-(S)-(4-flúor-2-metýl-fenýl)-píperasín-1-karboxýlsýru[1-(R)-(3,5-bis-tríflúor-2-metýl-fenýl)-etýl]-metýl-amíð til að meðhöndla þunglyndi og/eða kvíða - Google Patents

Samsetningar sem fela í sér paroxetín og 2-(S)-(4-flúor-2-metýl-fenýl)-píperasín-1-karboxýlsýru[1-(R)-(3,5-bis-tríflúor-2-metýl-fenýl)-etýl]-metýl-amíð til að meðhöndla þunglyndi og/eða kvíða

Info

Publication number: IS8128A
Authority: IS; Iceland
Prior art keywords: methyl; phenyl; carboxylic acid; paroxetine; trifluoro
Prior art date: 2003-04-17

Application number

IS8128A

Other languages

English (en)

Icelandic (is)

Inventor

Melotto Sergio

Corsi Mauro

Carletti Renzo

Original Assignee

Glaxo Group Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-04-17

Filing date

2005-11-15

Publication date

2005-11-15

2005-11-15 Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited

2005-11-15 Publication of IS8128A publication Critical patent/IS8128A/is

Links

AHOUBRCZNHFOSL-YOEHRIQHSA-N (+)-Casbol Chemical compound C1=CC(F)=CC=C1[C@H]1[C@H](COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-YOEHRIQHSA-N 0.000 title 1
-1 4-fluoro-2-methyl-phenyl Chemical group 0.000 title 1
208000019901 Anxiety disease Diseases 0.000 title 1
AHOUBRCZNHFOSL-UHFFFAOYSA-N Paroxetine hydrochloride Natural products C1=CC(F)=CC=C1C1C(COC=2C=C3OCOC3=CC=2)CNCC1 AHOUBRCZNHFOSL-UHFFFAOYSA-N 0.000 title 1
230000036506 anxiety Effects 0.000 title 1
239000000203 mixture Substances 0.000 title 1
229960002296 paroxetine Drugs 0.000 title 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Plural Heterocyclic Compounds (AREA)

IS8128A 2003-04-17 2005-11-15 Samsetningar sem fela í sér paroxetín og 2-(S)-(4-flúor-2-metýl-fenýl)-píperasín-1-karboxýlsýru[1-(R)-(3,5-bis-tríflúor-2-metýl-fenýl)-etýl]-metýl-amíð til að meðhöndla þunglyndi og/eða kvíða IS8128A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0308968.7A GB0308968D0 (en)	2003-04-17	2003-04-17	Medicaments
PCT/EP2004/004126 WO2004091624A1 (fr)	2003-04-17	2004-04-16	Combinaison comprenant paroxetine et 2- (s) - (4-fluoro-2-methyl-phenyl) -piperazine-1-acide carboxylique [1- (r)- (3,5-bis-trifluoro-2-methyl-phenyl) -ethyl]-methyl amide destinee au traitement de la depression et/ou de l'anxiete

Publications (1)

Publication Number	Publication Date
IS8128A true IS8128A (is)	2005-11-15

Family

ID=9956996

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IS8128A IS8128A (is)	2003-04-17	2005-11-15	Samsetningar sem fela í sér paroxetín og 2-(S)-(4-flúor-2-metýl-fenýl)-píperasín-1-karboxýlsýru[1-(R)-(3,5-bis-tríflúor-2-metýl-fenýl)-etýl]-metýl-amíð til að meðhöndla þunglyndi og/eða kvíða
IS8129A IS8129A (is)	2003-04-17	2005-11-15	Samsetningar paroxetíns og 4-(S)-(4-asetýl-píperasín-1-ýl)-2-(R)-(4-flúor-2-metýl-fenýl)-píperídín-1-karboxýlsýru [1-(R)-(3,5-bis-tríflúormetýl-fenýl)etýl]-metýlamíðs til að meðhöndla þunglyndi og/eða kvíða

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IS8129A IS8129A (is)	2003-04-17	2005-11-15	Samsetningar paroxetíns og 4-(S)-(4-asetýl-píperasín-1-ýl)-2-(R)-(4-flúor-2-metýl-fenýl)-píperídín-1-karboxýlsýru [1-(R)-(3,5-bis-tríflúormetýl-fenýl)etýl]-metýlamíðs til að meðhöndla þunglyndi og/eða kvíða

Country Status (18)

Country	Link
US (4)	US20060287325A1 (fr)
EP (4)	EP1615641A1 (fr)
JP (4)	JP2006523652A (fr)
KR (2)	KR20060003876A (fr)
CN (2)	CN1809355A (fr)
AU (2)	AU2004229181A1 (fr)
BR (2)	BRPI0409377A (fr)
CA (2)	CA2522313A1 (fr)
CO (1)	CO5700753A2 (fr)
GB (1)	GB0308968D0 (fr)
IS (2)	IS8128A (fr)
MA (2)	MA27731A1 (fr)
MX (2)	MXPA05011064A (fr)
NO (2)	NO20055368L (fr)
PL (2)	PL377857A1 (fr)
RU (2)	RU2005135649A (fr)
WO (4)	WO2004091617A1 (fr)
ZA (2)	ZA200508068B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0203020D0 (en)	2002-02-08	2002-03-27	Glaxo Group Ltd	Chemical compounds
GB0403149D0 (en) *	2004-02-12	2004-03-17	Glaxo Group Ltd	Medicament
GB0409098D0 (en) *	2004-04-23	2004-05-26	Glaxo Group Ltd	Medicament
GB0426942D0 (en) *	2004-12-08	2005-01-12	Glaxo Group Ltd	Medicament
WO2007012968A2 (fr) *	2005-07-29	2007-02-01	Aurobindo Pharma Ltd	Forme dosifee stable d'un antidepresseur
GB0621229D0 (en) *	2006-10-20	2006-12-06	Glaxo Group Ltd	Novel use
EP2117538A1 (fr)	2007-01-24	2009-11-18	Glaxo Group Limited	Compositions pharmaceutiques contenant du 2-méthoxy-5- (5-trifluorométhyl-tétrazol-i-yl-benzyl) - (2s-phényl-pipéridin-3s-yl-)
WO2012175434A1 (fr) *	2011-06-20	2012-12-27	Glaxo Group Limited	Formulations pharmaceutiques comprenant du vestipitant
CN103446066B (zh) *	2013-09-16	2014-12-24	南通丝乡丝绸有限公司	帕罗西汀冻干粉针及其制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IS4208A (is) *	1993-09-22	1995-03-23	Glaxo Group Limited	3-(tetrazólýl-benzyl)amínó-piperadidín afleiður
US6117855A (en) *	1996-10-07	2000-09-12	Merck Sharp & Dohme Ltd.	Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent
EP0977573A1 (fr) *	1997-04-24	2000-02-09	MERCK SHARP & DOHME LTD.	Utilisation d'un antagoniste du recepteur nk-1 et d'un inhibiteur selectif de reabsorption de la serotonine (ssri) dans le traitement de l'obesite
GB9923748D0 (en) *	1999-10-07	1999-12-08	Glaxo Group Ltd	Chemical compounds
US6436928B1 (en) *	1999-12-17	2002-08-20	Schering Corporation	Selective neurokinin antagonists
ES2258485T3 (es) *	1999-12-17	2006-09-01	Schering Corporation	Antagonistas selectivos de neuroquinina.
GT200100147A (es) *	2000-07-31	2002-06-25		Derivados de imidazol
GB0025354D0 (en) *	2000-10-17	2000-11-29	Glaxo Group Ltd	Chemical compounds
GB0119797D0 (en) *	2001-08-14	2001-10-03	Glaxo Group Ltd	Chemical compounds
DE60222693T2 (de) *	2001-11-13	2008-07-17	Schering Corp.	Nk1-antagonisten
GB0203020D0 (en) *	2002-02-08	2002-03-27	Glaxo Group Ltd	Chemical compounds

2003
- 2003-04-17 GB GBGB0308968.7A patent/GB0308968D0/en not_active Ceased
2004
- 2004-04-16 AU AU2004229181A patent/AU2004229181A1/en not_active Abandoned
- 2004-04-16 US US10/552,982 patent/US20060287325A1/en not_active Abandoned
- 2004-04-16 PL PL377857A patent/PL377857A1/pl not_active Application Discontinuation
- 2004-04-16 KR KR1020057019521A patent/KR20060003876A/ko not_active Withdrawn
- 2004-04-16 CA CA002522313A patent/CA2522313A1/fr not_active Abandoned
- 2004-04-16 WO PCT/EP2004/004124 patent/WO2004091617A1/fr not_active Ceased
- 2004-04-16 JP JP2006505188A patent/JP2006523652A/ja active Pending
- 2004-04-16 CA CA002522311A patent/CA2522311A1/fr not_active Abandoned
- 2004-04-16 AU AU2004229179A patent/AU2004229179A1/en not_active Abandoned
- 2004-04-16 WO PCT/EP2004/004121 patent/WO2004091615A1/fr not_active Ceased
- 2004-04-16 PL PL377858A patent/PL377858A1/pl not_active Application Discontinuation
- 2004-04-16 US US10/552,871 patent/US20060217395A1/en not_active Abandoned
- 2004-04-16 BR BRPI0409377-1A patent/BRPI0409377A/pt not_active Application Discontinuation
- 2004-04-16 RU RU2005135649/15A patent/RU2005135649A/ru not_active Application Discontinuation
- 2004-04-16 KR KR1020057019520A patent/KR20060003875A/ko not_active Withdrawn
- 2004-04-16 MX MXPA05011064A patent/MXPA05011064A/es unknown
- 2004-04-16 EP EP04739085A patent/EP1615641A1/fr not_active Withdrawn
- 2004-04-16 WO PCT/EP2004/004126 patent/WO2004091624A1/fr not_active Ceased
- 2004-04-16 US US10/552,869 patent/US20060241124A1/en not_active Abandoned
- 2004-04-16 JP JP2006505186A patent/JP2006523650A/ja active Pending
- 2004-04-16 EP EP04727896A patent/EP1653956A1/fr not_active Withdrawn
- 2004-04-16 WO PCT/EP2004/004122 patent/WO2004091616A1/fr not_active Ceased
- 2004-04-16 JP JP2006505187A patent/JP2006523651A/ja active Pending
- 2004-04-16 US US10/552,870 patent/US20060241143A1/en not_active Abandoned
- 2004-04-16 EP EP04739086A patent/EP1615642A1/fr not_active Withdrawn
- 2004-04-16 CN CNA2004800171620A patent/CN1809355A/zh active Pending
- 2004-04-16 EP EP04727895A patent/EP1613325A1/fr not_active Withdrawn
- 2004-04-16 JP JP2006505185A patent/JP2006523649A/ja active Pending
- 2004-04-16 RU RU2005135647/15A patent/RU2005135647A/ru not_active Application Discontinuation
- 2004-04-16 MX MXPA05011063A patent/MXPA05011063A/es unknown
- 2004-04-16 CN CNA2004800172252A patent/CN1809359A/zh active Pending
- 2004-04-16 BR BRPI0409379-8A patent/BRPI0409379A/pt not_active Application Discontinuation
2005
- 2005-10-06 ZA ZA200508068A patent/ZA200508068B/en unknown
- 2005-10-06 ZA ZA200508067A patent/ZA200508067B/en unknown
- 2005-10-14 CO CO05105292A patent/CO5700753A2/es not_active Application Discontinuation
- 2005-10-19 MA MA28562A patent/MA27731A1/fr unknown
- 2005-10-19 MA MA28561A patent/MA27730A1/fr unknown
- 2005-11-14 NO NO20055368A patent/NO20055368L/no not_active Application Discontinuation
- 2005-11-14 NO NO20055367A patent/NO20055367L/no not_active Application Discontinuation
- 2005-11-15 IS IS8128A patent/IS8128A/is unknown
- 2005-11-15 IS IS8129A patent/IS8129A/is unknown

Also Published As

Publication number	Publication date
AU2004229179A1 (en)	2004-10-28
JP2006523652A (ja)	2006-10-19
KR20060003875A (ko)	2006-01-11
US20060217395A1 (en)	2006-09-28
EP1613325A1 (fr)	2006-01-11
US20060241124A1 (en)	2006-10-26
NO20055367L (no)	2005-11-14
MA27731A1 (fr)	2006-01-02
BRPI0409379A (pt)	2006-04-25
CN1809359A (zh)	2006-07-26
RU2005135647A (ru)	2006-06-10
MXPA05011064A (es)	2006-04-18
EP1615641A1 (fr)	2006-01-18
EP1653956A1 (fr)	2006-05-10
CO5700753A2 (es)	2006-11-30
AU2004229181A1 (en)	2004-10-28
NO20055368L (no)	2005-11-14
WO2004091624A1 (fr)	2004-10-28
PL377858A1 (pl)	2006-02-20
RU2005135649A (ru)	2006-03-20
US20060241143A1 (en)	2006-10-26
WO2004091617A1 (fr)	2004-10-28
EP1615642A1 (fr)	2006-01-18
JP2006523651A (ja)	2006-10-19
JP2006523650A (ja)	2006-10-19
WO2004091616A1 (fr)	2004-10-28
CA2522313A1 (fr)	2004-10-28
MA27730A1 (fr)	2006-01-02
PL377857A1 (pl)	2006-02-20
CN1809355A (zh)	2006-07-26
JP2006523649A (ja)	2006-10-19
CA2522311A1 (fr)	2004-10-28
WO2004091615A1 (fr)	2004-10-28
GB0308968D0 (en)	2003-05-28
MXPA05011063A (es)	2005-12-12
IS8129A (is)	2005-11-15
KR20060003876A (ko)	2006-01-11
BRPI0409377A (pt)	2006-04-25
ZA200508067B (en)	2007-02-28
US20060287325A1 (en)	2006-12-21
ZA200508068B (en)	2007-02-28

Publication	Publication Date	Title
IS8214A (is)	2005-12-30	3,5 tvísetin indasól enfasambönd, lyfjasamsetningar, og aðferðir til að miðla eða hindra frumufjölgun
IS7717A (is)	2005-02-28	Pýrídasínónafleiður sem PDF4-hemlar
DE602005011795D1 (de)	2009-01-29	Inhibitoren von 11-beta-hydroxysteroiddehydrogenase typ 1
DK1537759T3 (da)	2014-10-27	Fremgangsmåde til at modvirke okklusionseffekter
IS7792A (is)	2005-04-11	Hýdantóínafleiður og notkun þeirra sem TACE hemla
EP2620150A3 (fr)	2014-01-08	Inhibiteurs à base de 2-amido thiazole d'enzymes utilisant l'ATP
IL164400A (en)	2010-11-30	Derivatives of n - [phenyl(piperidin-2 - yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
IS7483A (is)	2004-10-01	Bensamíðafleiður gagnlegar sem históndeasetýlasatálmar
PL376524A1 (pl)	2006-01-09	Nowe hydroksyindole, ich zastosowanie jako inhibitorów fosfodiesterazy 4 i sposób ich wytwarzania
EP1911757B8 (fr)	2011-05-25	Procédé de préparation de 3-(1,3-Dihydroimidazole-2-thione-1-yl)-chromanes et thiochromanes en tant que inhibiteurs de la dopamine-beta-hydroxylase
EP1608225A4 (fr)	2007-07-04	Interventions chirurgicales thermiques et compositions associees
DK1484970T3 (da)	2013-10-07	Benzamider og sammensætninger omfattende benzamider til anvendelse som fungicider
NO20050652L (no)	2005-03-08	Pyrrolidone derivater som maob inhibitorer
FI20021660L (fi)	2004-03-18	Hiilihydraattien uusi käyttö ja koostumukset
AU2003286474A8 (en)	2004-05-04	Compositions, solutions, and methods used for transplantation
WO2004064832A3 (fr)	2004-12-16	Methodes pour traiter les douleurs articulaires ou ameliorer le sommeil a l'aide d'un agoniste/antagoniste des oestrogenes
EP1663255A4 (fr)	2012-02-01	Compositions de withanamide and withanolide et procede d'utilisation de celles-ci
IS8128A (is)	2005-11-15	Samsetningar sem fela í sér paroxetín og 2-(S)-(4-flúor-2-metýl-fenýl)-píperasín-1-karboxýlsýru[1-(R)-(3,5-bis-tríflúor-2-metýl-fenýl)-etýl]-metýl-amíð til að meðhöndla þunglyndi og/eða kvíða
IL172542A0 (en)	2006-04-10	2-hydroxymethyl-3,4,5-trihydroxy-1-benzilpiperidine derivatives as inhibitors of glucosylceramide
IL176515A0 (en)	2006-10-05	1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same
EP1709206A4 (fr)	2008-01-23	Compositions et methodes de modulation de l'activite de la sirtuine
ATE373648T1 (de)	2007-10-15	Nf-kappab-inhibitoren
DE60315255D1 (de)	2007-09-13	Zusammensetzung und verfahren zur bekämpfung von termiten
IS7666A (is)	2005-01-26	N-súlfónýlpíperídín sem málmprótínkljúfatálmar (TACE)
ATE493390T1 (de)	2011-01-15	2,3-diaryl-pyrazolidine derivate als neurotensin abbauende enzyme-inhibitoren